Search Ontology:
ChEBI
(3S,4R,5R,10R,13R,14R,17R)-4-(Hydroxymethyl)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
- Term ID
- CHEBI:181346
- Synonyms
-
- (3S,4R,5R,10R,13R,14R,17R)-4-(hydroxymethyl)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
- Definition
- References
-
- KEGG:C04814
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from (3S,4R,5R,10R,13R,14R,17R)-4-(Hydroxymethyl)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
Phenotype where environments contain (3S,4R,5R,10R,13R,14R,17R)-4-(Hydroxymethyl)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
Phenotype modified by environments containing (3S,4R,5R,10R,13R,14R,17R)-4-(Hydroxymethyl)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
Human Disease Model